Sustaining Remission of Psychotic Depression.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 12 Jun 2017
At a glance
- Drugs Olanzapine (Primary) ; Sertraline
- Indications Major depressive disorder; Psychotic disorders
- Focus Therapeutic Use
- Acronyms STOP-PD; STOP-PD-II
- 08 Jun 2017 Planned number of patients changed from 392 to 269.
- 08 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jan 2017 Planned End Date changed from 1 Aug 2017 to 1 Mar 2018.